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Background: The HBx oncoprotein of hepatitis B virus has been implicated in the development and progression of
hepatocellular carcinoma (HCC). HBx engages multiple signalling and growth-promoting pathways to induce cell
proliferation and enhance ribosome biogenesis. Interestingly, the levels of Upstream Binding Factor (UBF) required
for rDNA transcription and ribosome biogenesis are found elevated in the HCC patients. However, the molecular
mechanism of UBF overexpression under the HBx microenvironment and consequent cell transformation remains
elusive.
Methods: The UBF gene expression was investigated after co-expressing HBx in immortalized human hepatocytes
(IHH) and human hepatoma Huh7 cells. Gene expression analysis involved estimation of mRNA level by real-time
PCR, western blotting of protein, chromatin immune-precipitation assay, BrdU incorporation assay and soft agar colony
formation assay. UBF expression was also investigated in an HBx transgenic mouse model of HCC to get a better
mechanistic insight under more physiological conditions.
Results: Ectopic expression of HBx in IHH as well as Huh7 cells led to a marked increase in UBF expression both
at mRNA and protein levels. Elevated levels of UBF were also observed in the hepatic tumors of HBx transgenic
mice. Our ChIP studies revealed a marked increase in the occupancy of c-Myc on the UBF gene promoter in the
presence of HBx and increase in its transcription. Enhanced UBF expression under the HBx microenvironment led
to a marked increase in cell proliferation and transformation of IHH cells.
Conclusions: Our study provides some compelling evidences in support of HBx-mediated increase in UBF levels
that abets oncogenic onslaught in hepatic cells by increasing rDNA transcription and ribosome biogenesis.
Keywords: HBx, Hepatitis B virus, Upstream Binding Factor, rDNA transcription, c-Myc, Cell proliferation, Cell
transformationBackground
Hepatocellular carcinoma (HCC) is the one of the most
prevalent human cancer causing third largest cancer
related deaths worldwide. Chronic Hepatitis B virus
(HBV) infection contributes to more than half of the
observed liver cancer cases and thus is a major risk fac-
tor of HCC [1]. The HBx oncoprotein encoded by the* Correspondence: vijay@icgeb.res.in
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unless otherwise stated.X gene of HBV is the main viral oncoprotein involved in
development of HCC; although molecular mechanism of
HBx-mediated HCC is still not fully understood [2]. HBx
has been shown to activate several growth signalling path-
ways and gene promoters, albeit it does not directly interact
with DNA. The transactivation function of HBx has been
extensively reviewed in the context of cell cycle, cell growth
and proliferation that is significantly altered during HCC
[3-6]. HBx modulates the expression profiles of host genes
by engaging certain transcription factors. The HBx-
responsive genes typically carry binding sites for c-Myc,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CCAAT/enhancer binding protein (CEBP), Activating tran-
scription factors/ c-CAMP response element binding pro-
tein ATF/CREB, or the calcium-activated factor NF-AT,
apparently stimulating their binding to the promoter ele-
ments [7]. Apart from Pol II-dependent promoters, HBx
can modulate the RNA Polymerase I activity which is char-
acteristic of several neoplastic growth [5]. However, the mo-
lecular mechanism of HBx-mediated RNA Polymerase I
activity regulation remains elusive.
The Upstream Binding Factor (UBF) is considered as a
major transcriptional regulator of RNA Pol I dependent
rRNA genes. UBF acts predominantly in the promoter
region and facilitate the loading of SL1 and RNA pol I.
Therefore, efficient binding of UBF to rRNA gene is a
pre-requisite for formation and assembly of initiation
complex [8-10]. In mammalian cells, the UBF gene
expression is regulated at both transcriptional and
post-transcriptional levels. During development and
differentiation, a diminished expression of UBF posi-
tively correlates with decreased rRNA synthesis while
the cell cycle-dependent rRNA synthesis is primarily
regulated through post-translational modifications of
UBF [8,11]. Not surprisingly, the intracellular level of
UBF is a key determinant of active rRNA genes [11].
Despite a critical role played by UBF in ribosome bio-
genesis, nothing much is known about the regulation
of UBF gene expression except for the involvement of
some growth regulators such as EGF, IGF and c-Myc
in the process [12-16].
Taking into consideration, the complex interplay be-
tween ribosome biogenesis and neoplastic transforma-
tions, it is not surprising to observe the altered levels of
UBF in many cancers such as breast and hepatic cancers
[17,18]. Importantly, elevated levels of UBF have also
been reported in some HCC patients [18]. Since the
HBx oncoprotein of HBV is the major causative agent in
the development of HCC, we wondered if UBF expres-
sion and activity was essential for hepatocarcinogenesis.
In the present study, we show that HBx can stimulate
the expression of UBF gene with the help of transcrip-
tion factor c-Myc. Further, UBF expression was essential
for enhanced cell proliferation and transformation under
the HBx microenvironment.
Results
HBx induces the expression of UBF in hepatic cell lines
Deregulation of UBF levels is frequently seen in cases of
HCC [18]. Therefore, the role of HBx in development of
HCC was investigated under HBx microenvironment.
The role of HBx in UBF expression was investigated
after transiently transfecting Huh7 and IHH cells with
either vector or HBx expression plasmid and monitoring
the UBF protein level by western blotting. There was amarked increase in UBF expression in the HBx trans-
fected cells as compared to control transfected cells
(Figure 1A and B). As expected, elevated levels of UBF
were also observed in HepG2.2.15 cells that carry an in-
tegrated copy of HBV genome and express HBx in com-
parison to the parent HepG2 cells (Figure 1C). Further,
our immunofluorescence studies confirmed increased
UBF expression in the presence of HBx (Figure 1D). As
HBx is implicated in the transcriptional up-regulation of
many cellular genes, we next investigated the transcrip-
tional regulation of UBF gene by HBx. RT-qPCR analysis
of the RNA isolated from the HBx-expressing cells con-
firmed a highly significant increase (p < 0.05) in the UBF
transcripts (Figure 1E, F and G). Collectively, these results
indicate that viral HBx can induce the expression of UBF
required for RNA polymerase I activity.
Elevated levels of UBF is found in the hepatic tumours of
X15-myc transgenic mice
As we observed elevated expressions of UBF in the pres-
ence of HBx, we next investigated UBF expression in a
tumour environment [19]. Analysis of the X15-myc
transgenic mice (different stage hepatic tumours) re-
vealed a significant increase in UBF expression both at
mRNA (p < 0.05) as well as protein levels in comparison
to control mice (Figure 2A and B). Further, the immuno-
histochemical analysis confirmed elevated UBF expression
in the transgenic liver tissues (see Additional file 1). These
observations confirmed an in vivo up-regulation of UBF
under the HBx microenvironment.
HBx modulates UBF expression by engaging c-Myc on the
UBF promoter
HBx is known to regulate the levels of many host pro-
teins either by engaging different transcription factors
or by interfering with their intracellular stability [7].
To understand the molecular mechanism of UBF gene
expression in the presence of HBx, we first examined
the role of transcription factors such as c-Myc which
is already reported to act as a key activator of UBF
gene expression [13]. Since viral HBx is known to
stabilize c-Myc and exhibit an oncogenic cooperation
with it, we next probed the regulation of UBF via c-
Myc [20,21]. In accordance with the stimulatory role
of c-Myc on UBF promoter, RNA interference against
c-Myc using specific shRNA, not only led to a dra-
matic decrease in the UBF gene expression (p < 0.05)
but also prevented the HBx-mediated gene stimulation
(p < 0.05) (Figure 3A). Thus, c-Myc appeared to be in-
dispensable for UBF gene stimulation under these
conditions. The regulatory action of c-Myc on UBF
was further investigated for its promoter occupancy in
the presence of HBx [13]. Our ChIP studies confirmed




Figure 1 Regulation of UBF expression under the HBx microenvironment. (A) & (B) Huh7 and IHH cells were transiently transfected with vector
or HBx expression plasmids. After 48 h, cell lysates were western blotted for UBF, HBx and GAPDH. (C) HepG2 and HepG2.2.15 cell extracts were
western blotted for UBF, HBx and GAPDH as above. (D) Huh7 cells were transiently transfected as in panel A and processed for immunofluorescence
with anti-UBF antibody (Red). DAPI staining (Blue) was used to visualize nuclei. Scale bar represents 50 μm (E) & (F), Huh7 and IHH cells were transiently
transfected as in panel A, B and total RNA was isolated for measuring UBF mRNA levels by RT-qPCR using primers mentioned in Additional file 1: Table
S1 (G) The UBF mRNA levels in asynchronously growing HepG2 and HepG2.2.15 cells was measured as above. All data are represented as mean ± S.D of
three independent experiments. * represents a statistically significant difference of p <0.05.
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Based on these observations, we conclude that viral
HBx stimulates UBF gene expression by enhancing the
promoter recruitment of transcriptional activator c-
Myc.UBF cooperates with HBx to stimulate cell proliferation
and tumorigenesis
UBF has been recognized as a critical regulator of rRNA
synthesis which constitutes nearly 80 per cent of the
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Figure 2 Expression levels of UBF in the hepatic tumours of X15- myc transgenic mice. (A) Total RNA from the liver tissues of 1, 3 and 6 months
old control and transgenic mice was isolated and subjected to RT- qPCR as described above. (B) Total cell lysate of liver tissues of 1, 3 and
6 months old control and transgenic mice were western blotted for UBF, HBx and GAPDH. Data are shown as mean ± S.D of three independent
experiments. * represents a statistically significant difference of p <0.05.
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thesis [8]. Since HBx plays an extensive role in cell
cycle progression and cellular proliferation, we won-
dered if enhanced expression of UBF under the HBx
microenvironment also contributed towards these pro-
cesses. Keeping these issues in mind, we first studied
the effect of UBF over-expression on proliferation and
survival of hepatic cells. As shown in Figure 4A, we ob-
served a significantly (p < 0.05) accelerated entry of cells
into S phase following UBF overexpression. Consist-
ently, after 72 hours post-transfection UBF overexpress-
ing hepatic cells exhibited significantly (p < 0.05) better
survival in comparison to control cells. (Figure 4B).
The observation was further characterized in presence
of HBx by BrdU incorporation cell proliferation assay
following ectopic expression of UBF and HBx. Therewas a significant increase (p < 0.05) in the proliferation
of cells expressing either HBx or UBF alone. However,
the cells co-expressing HBx and UBF showed signifi-
cantly higher (p < 0.05) BrdU incorporation in com-
parison to cells expressing HBx or UBF alone
(Figure 5A). These results suggested that HBx and
UBF act cooperatively to drive cell proliferation in
hepatic cells.
In line with the preceding observations, we further
investigated the cooperative oncogenic capacity of
HBx and UBF using a soft agar cell transformation
assay. IHH cells transfected with UBF and HBx were
examined for colony formation under phase contrast
light microscope (Figure 5B). As anticipated, cells co-
expressing UBF and HBx showed increased average































































Figure 3 c-Myc- dependent transcriptional regulation of UBF in the presence of HBx. (A) Huh7 cells were transiently transfected with vector, HBx
and/or Myc- shRNA plasmids. Total RNA was isolated and the levels of UBF mRNA were measured by RT-qPCR. (B) IHH cells were transiently
transfected with vector or HBx expression plasmids. After 48 h, cells were subjected to ChIP assay using 'anti-Myc antibody. Pre-immune sera
were used as a negative control. Fold DNA enrichment over mock due to UBF occupancy was measured by ChIP-qPCR using primers specific
for UBF promoter (Additional file 1: Table S1). Data are shown as mean ± S.D of three independent experiments. * represents a statistically
significant difference of p <0.05.
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cooperative role of UBF and HBx in oncogenic trans-
formation of hepatocytes.
Discussion
The transcriptional activity of RNA polymerase I is es-
sential for ribosome biogenesis which is required for
supporting the translational capacity of cells as well as
cell proliferation. In this process, the upstream binding
factor or UBF is engaged as a key transcriptional regula-
tor [8-10]. Thus, the cellular levels of UBF determine
the number of active rRNA genes and the rate of ribo-
some biogenesis [11]. Importantly, it has been previously
reported that UBF is significantly up regulated in HCC
patients [18]. In accordance to this, the NS5A protein of
Hepatitis C virus has been reported to activate RNA
polymerase I transcription through UBF phosphorylation
[22]. On the other hand, the Hepatitis B virus oncopro-
tein HBx is also known for its pro-proliferative effects
on hepatic cells through modulation of various cellular
pathways [7]. Although, HBx has been implicated in the
regulation of RNA polymerase I transcription via acti-
vated Rat Sarcoma (Ras) and TATA binding protein
(TBP), there is no direct evidence associating viral HBx
with UBF functions [5]. Therefore, keeping the above
background into consideration, in the current study, we
have probed the molecular mechanism of oncogenic co-
operation between viral HBx and cellular UBF.
Considering a formidable trans-activation function as-
sociated with HBx, here we studied its role in the ex-
pression of UBF gene. Our results clearly suggested thatHBx could induce UBF expression in different hepatic
cell lines (Figure 1). Elucidating the molecular mechan-
ism of HBx action, we show that UBF gene was a tran-
scriptional target of HBx where the transcription factor
c-Myc played a pivotal role in UBF expression. This is
in perfect agreement with our previous observation
where we have showed increased intracellular
stabilization of c-Myc under the HBx microenviron-
ment [21]. We believe that accumulated intracellular c-
Myc in presence of HBx is associated with enhanced
UBF gene expression and its pathological consequences.
Not surprisingly, c-Myc accumulation was associated
with a surge in its recruitment to the UBF gene pro-
moter (Figure 3). These observations are in concord
with the finding that proto-oncogene c-Myc mediates
its oncogenic effects through deregulating the expres-
sion of its target genes [23]. The physiological relevance
of c-Myc dependent UBF expression in the presence of
HBx was also evident from its elevated levels in the
hepatic tumour microenvironment of X15-myc trans-
genic mice (Figure 2). The histopathological changes in
the X15-myc transgenic mice become evident in as
early as 1 month old transgenic mice with concomitant
expression of c-Myc resulting in the emergence of a
multi-focal, well differentiated HCC by the end of
6 months [19]. Our current observation that UBF levels
were significantly altered in even 1 month old trans-
genic mice with gradual increase in the 6 month old
transgenic mice reinforced the importance of c-Myc
dependent UBF expression in cell proliferation and
transformation leading to HCC development.
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Figure 4 Effect of UBF overexpression on cell proliferation and cell survival of hepatoma cells. (A) Cell cycle distribution of vector or UBF transfected
Huh7 cells represented as percentage of total cells in different phases. (B) Huh7 cells were transiently transfected with vector or UBF expression plasmids.
Cell viability was measured by MTT assay. All quantitative values are mean ± S.D of three independent experiments. * represents a statistically significant
difference of p <0.05.
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rRNA gene transcription and ribosome biogenesis, it
was of great relevance to study the patho-physiological
consequence of increased UBF levels under the HBx
microenvironment. Our studies indicate that surplusUBF was actively recruited to the rDNA in the presence
of HBx, facilitating epigenetic alterations and increased
rRNA levels (Ahuja et al., unpublished data) leading to
enhanced ribosome biogenesis. UBF has also been impli-
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Figure 5 (See legend on next page.)
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Figure 5 Cooperation between UBF and HBx in cell proliferation and transformation. (A) Huh7 cells transiently transfected with indicated plasmids are
synchronized in S-phase by thymidine block. Following BrdU incorporation, cells were subjected to staining with antibody against BrdU and counterstained
with DAPI, and the number of BrdU-positive cells was counted. Scale bar represents 50 μm. (B) IHH cells were transfected with indicated plasmids and
allowed to grow in soft agar for 15 days and visualized under microscope for colony formation. Scale bar represents 10 μm. All quantitative values are
mean ± S.D of three independent experiments. * represents a statistically significant difference of p <0.05.
HBV’s  HBx oncoprotein
c-Myc






Figure 6 Schematic illustration depicting the mechanism of increase
in UBF expression under the HBx microenvironment and its implication
in development of HCC.
Rajput et al. Virology Journal  (2015) 12:62 Page 8 of 11myeloid cells [24]. Now, we show that ectopic expression
of UBF in hepatic cells was associated with accelerated
G1-S transition and cell proliferation (Figure 4). This
prompted us to investigate if there was cooperation be-
tween UBF and HBx that resulted in an increased cell
proliferation and oncogenic transformation. Using BrdU
incorporation and soft agar colony formation assay, we
demonstrate that UBF and HBx cooperated during hepatic
cell proliferation leading to their oncogenic transformation
(Figure 5). Thus, it may be inferred that HBx-mediated
oncogenesis can, in part, be owed to UBF being a regulator
of RNA polymerase I transcription, resulting in increased
cell proliferation and growth, ultimately leading to HCC.
Collectively, UBF appears to be an important mediator
of the HBx oncogenic activity by stimulating ribosome
biogenesis and contributing towards cell proliferation
and transformation.
Conclusions
In conclusion, we show that Hepatitis B virus oncopro-
tein HBx induces c-Myc dependent transcription of UBF
gene resulting in its enhanced expression in hepatic cell
lines. As summarized in Figure 6, increased UBF expression
cooperates with HBx to stimulate cell proliferation and
oncogenesis.
Methods
Expression vectors and chemical reagents
The HBx expression plasmid has been described previ-
ously [19]. UBF-pcDNA expression vector was kind gift
from Prof. Ross Hanahann, Peter Maculum Cancer
Centre, Melbourne, Australia. Antibodies for HBx, UBF
and c-Myc were purchased from Santa Cruz Biotechnology,
USA. The Myc shRNA used in the study has been devel-
oped in our laboratory by cloning individual oligos directed
against the transactivation and leucine zipper domain of c-
Myc protein in pSilencerU6 1.0 vector [25].
Chemical reagents such as Propidium iodide and MTT
were purchased from Sigma Chemical Co. (St Louis, MO).
Dulbecco’s modified Eagle’s medium (DMEM), Fetal bo-
vine serum (FBS), Streptomycin and Penicillin were pur-
chased from Gibco BRL.
Cell culture and transfection
The Immortalized Human Hepatocytes (IHH) cells were
provided as kind gift from Dr. Fanny Daniel, Institut
National de la Santé et de la Recherche Médicale Unite481, Universite Paris 7, Paris, France. The maintenance
of human hepatoma Huh7, HepG2, HepG2.2.15 cells
have been described previously [26]. All cell lines were
cultured in DMEM supplemented with 10% FBS and
incubated at 37°C in a humidified chamber with 5-10%
CO2. Seeding was done at a density of 0.6 million cells
per 60 mm dish or 0.1 million cells/well (12-well plate)
and transfection of all plasmid DNA was performed
using Lipofectamine (Invitrogen, CA, USA) as per
manufacturer’s protocol. Transfection efficiency was
found ~70 per cent.
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Western blotting of protein samples was done as de-
scribed previously [26]. Briefly, cells were directly har-
vested in 2X Laemilli’s buffer and boiled for 5 minutes
in a water bath. The liver tissue samples were homoge-
nized in the lysis buffer (20 mM Tris- HCl pH 7.5,
150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 10 mM
DTT, 1 mM Sodium Fluoride, 10 mM β -glycerol phos-
phate, 1 mM EGTA, 2 mM PMSF, 1.5 mM MgCl2) for
2 h at 25°C. The protein estimation was done by the
Bradford assay. Equal amount of protein was loaded
onto SDS gel and processed for western blotting. The
analysis was done using Enhanced chemi-luminescence
technique detected on a Kodak X-Ray film. The protein
levels were quantified through densitometry using the
ImageJ software.RNA isolation and real time quantitative PCR (RT-qPCR)
TRIzol reagent was used to isolate RNA as per manu-
facturer’s instructions. M-MuLV Reverse transcriptase
(Fermentas) was used to reverse transcribe total RNA
using oligo dT primers according to manufacturer’s
guidelines. RT-qPCR was performed using Universal
SYBR green mix (Biorad). ARPP mRNA was used as an
internal control and the results were analyzed using
comparative ΔΔCt method [27]. Primer sequences used
are listed in Table S1 (see Additional file 1).
Chromatin Immunoprecipitation assay (ChIP)
Chromatin immuno-precipitation assay was carried out
according to manufacturer’s instructions (Upstate Bio-
technology). Briefly, the crosslinked chromatin was
immunoprecipitated using c-Myc antibody (N-262X,
Santa Cruz). Subsequently, the immunoprecipitated
DNA was purified by phenol-chloroform extraction
followed by ethanol precipitation. Thus obtained purified
DNA was amplified by real time PCR using Universal
SYBER green mix (Biorad) with indicated primers listed
in Table S1(see Additional file 1). The data obtained was
normalized with input DNA and expressed as fold DNA
enrichment over pre immune sera.
Flow cytometry analysis and cell viability assay
Flow cytometry of cells was done as described elsewhere
[26]. Cell viability was examined in transfected cells
using MTT assay. Cells were seeded at 0.5x106 cells and
transfected with vector or UBF expressing plasmid. After
48 h of transfection, cells were incubated with MTT at
37°C for 45 min. Crystals were solubilized using molecular
grade DMSO and the absorbance was recorded at 560 nm
using spectrophotometer. The mean absorbance values of
three independent experiments were expressed as per-
centage of viability in relative to control cells.Immunofluorescence assay
Immunofluorescence assay was performed as described
previously [28]. Briefly, Huh7 cells were transiently
transfected with indicated expression plasmid. After
48 h post-transfection, cells were fixed with 2% formal-
dehyde and immunofluorescence staining was per-
formed. The images were captured with the help of
Nikon ECLIPSE TE 2000-U fluorescent microscope
(Nikon Instrument Inc., USA) using 60x objective lens.Animal tumour model
The development of the X15-myc transgenic mice model
of hepatocellular carcinoma (HCC) used in current
study, has been described earlier [19]. PCR based
methods were used to identify transgene-positive trans-
genic mice. Liver tissue samples were collected from dif-
ferent aged mice for the extraction of total RNA and
protein samples. Normal mice of the same age groups
served as internal control.Immunohistochemistry (IHC) of liver tissues
The avidin–biotin complex (ABC) method of IHC was
used to determine UBF expression in the liver samples
of normal C57/Blk6 and X15-myc transgenic mice by
IHC. Briefly, paraffin sections of liver tissues were proc-
essed for antigen retrieval by first dewaxing in xylene,
rehydration and treatment with 3% hydrogen peroxide
followed by incubating in citrate buffer (pH 6.0) in a
boiling water bath for 15–20 min. The sections were
blocked with goat serum for 20 min and incubated with
mouse anti-UBF (at a 1:300 dilution in PBS and 1%
BSA). The samples were then processed for IHC analysis
using the Dao Cytomation-LSAB system and an HRP kit
(Dako) according to the manufacturer’s protocol. Finally,
the sections were counterstained with haematoxylin and
mounted with DPX. The bright field images were cap-
tured with the help of Nikon ECLIPSE TE 2000-U fluor-
escent microscope (Nikon Instrument Inc., Melville, NY,
USA) using 20x objective lens.
BrdU incorporation assay
Huh7 cells were seeded at a density of 0.1 million cells
in a 12 well plate. They were transiently transfected with
vector, HBx or UBF expression plasmid. After 48 hours
post-transfection, cells were treated with thymidine
(2 mM) for 24 hours. After 5 hour of release in complete
media, cells were labelled with BrdU as per manufac-
turer’s guidelines (BrdU labelling kit, Roche Diagnostics).
A total of 6 fields was selected to count the number of
BrdU-positive cells and the total number of cells and the
percentage of BrdU-positive cells was then estimated.
The mean value of three experiments is presented.
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IHH cells in a 6- well plate were transfected with with
vector, HBx or UBF expression plasmids. After 72 h
post-transfection, cells were trypsinized, and mixed with
0.4% agar in 2 × DMEM. The mixture was then layered
upon 0.8% agar prepared in 2 × DMEM containing 10%
FBS. Bright-field images of transformed colonies were
captured with a Nikon ECLIPSE TE 2000-S microscope.
An approximate of 10 random fields were selected to
calculate the number of foci formed on each plate. The
mean value of three experiments is presented.
Statistical analysis
Statistical significance of results was calculated using
Student’s t test. p value < 0.05 was considered as significant.
Additional file
Additional file 1: Table S1. Oligonucleotide primers used for RT-qPCR
and ChIP-qPCR. Figure S1. Expression levels of UBF in X15-myc transgenic
mice. Immunohistochemical detection of UBF in the liver tissues of 6-month
old control and X15-myc transgenic mice. (Original image magnification,×200).
Scale bar represents10 um.
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